SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001171843-20-000981
Filing Date
2020-02-14
Accepted
2020-02-14 08:00:15
Documents
10
Period of Report
2020-02-13

Document Format Files

Seq Description Document Type Size
1 FORM 6-K f6k_021320.htm 6-K 11037
2 EXHIBIT 99.1 exh_991.htm EX-99.1 377623
3 EXHIBIT 99.2 exh_992.htm EX-99.2 521216
4 EXHIBIT 99.3 exh_993.htm EX-99.3 10026
5 EXHIBIT 99.4 exh_994.htm EX-99.4 10120
6 GRAPHIC logo.jpg GRAPHIC 79437
7 GRAPHIC mda_pg8.jpg GRAPHIC 462212
8 GRAPHIC mda_pg14.jpg GRAPHIC 82648
9 GRAPHIC mda_pg15.jpg GRAPHIC 303135
10 GRAPHIC mda_pg16.jpg GRAPHIC 180665
  Complete submission text file 0001171843-20-000981.txt   2454027
Mailing Address 545 PROMENADE DU CENTROPOLIS, SUITE 100 LAVAL A8 H7T 0A3
Business Address 545 PROMENADE DU CENTROPOLIS, SUITE 100 LAVAL A8 H7T 0A3 450-686-4555
Acasti Pharma Inc. (Filer) CIK: 0001444192 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 0331
Type: 6-K | Act: 34 | File No.: 001-35776 | Film No.: 20613967
SIC: 2834 Pharmaceutical Preparations